Systemic administration of the murine analogue NHS-muIL12 delayed the growth of MC38-CEA+ colorectal carcinomas in carcinoembryonic antigen transgenic (CEA.Tg) mice (137). Here, CEACAM5 is linked to colorectal carcinoma.